174 related articles for article (PubMed ID: 17604763)
1. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation.
Chen MH; Yang W; Yan K; Dai Y; Wu W; Fan ZH; Callstrom MR; Charboneau JW
Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763
[TBL] [Abstract][Full Text] [Related]
2. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.
Kisaka Y; Hirooka M; Kumagi T; Uehara T; Hiasa Y; Kumano S; Tanaka H; Michitaka K; Horiike N; Mochizuki T; Onji M
Liver Int; 2006 Dec; 26(10):1241-7. PubMed ID: 17105590
[TBL] [Abstract][Full Text] [Related]
4. [Application of contrast-enhanced ultrasonography in selecting indication of radiofrequency ablation among hepatocellular carcinoma patients].
Chen MH; Wu W; Yang W; Gao W; Dai Y; Yin SS; Huo L; Yan K
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3491-4. PubMed ID: 16686066
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation of liver tumors: the role of microbubble ultrasound contrast agents.
Meloni MF; Livraghi T; Filice C; Lazzaroni S; Calliada F; Perretti L
Ultrasound Q; 2006 Mar; 22(1):41-7. PubMed ID: 16641792
[TBL] [Abstract][Full Text] [Related]
6. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.
Tarantino L; Francica G; Sordelli I; Esposito F; Giorgio A; Sorrentino P; de Stefano G; Di Sarno A; Ferraioli G; Sperlongano P
Abdom Imaging; 2006; 31(5):537-44. PubMed ID: 16865315
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings.
Cao J; Dong Y; Mao F; Wang W
Biomed Res Int; 2018; 2018():6469703. PubMed ID: 30225261
[TBL] [Abstract][Full Text] [Related]
9. High mechanical index post-contrast ultrasonography improves tissue structural display of hepatocellular carcinoma.
Chen MH; Yang W; Dai Y; Wu W
Chin Med J (Engl); 2005 Dec; 118(24):2046-51. PubMed ID: 16438901
[TBL] [Abstract][Full Text] [Related]
10. [Results of enhanced ultrasonography in assessing hepatoma treated with radiofrequency ablation].
Yan K; Chen MH; Dai Y; Shen L; Jiang XL
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):41-4. PubMed ID: 15771798
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach.
Chen MH; Yang W; Yan K; Hou YB; Dai Y; Gao W; Zhang H; Wu W
Abdom Imaging; 2008; 33(4):428-36. PubMed ID: 17639375
[TBL] [Abstract][Full Text] [Related]
12. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound.
Solbiati L; Ierace T; Tonolini M; Cova L
Eur J Radiol; 2004 Jun; 51 Suppl():S19-23. PubMed ID: 15311434
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategy to optimize radiofrequency ablation for liver malignancies.
Chen MH; Wei Y; Yan K; Gao W; Dai Y; Huo L; Yin SS; Zhang H; Poon RT
J Vasc Interv Radiol; 2006 Apr; 17(4):671-83. PubMed ID: 16614151
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
15. Enhancement pattern of hepatocellular carcinoma: comparison of real-time contrast-enhanced ultrasound and contrast-enhanced computed tomography.
Liu GJ; Xu HX; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
Clin Imaging; 2006; 30(5):315-21. PubMed ID: 16919551
[TBL] [Abstract][Full Text] [Related]
16. [Identification the invasion range of hepatocellular carcinoma by contrast-enhanced ultrasound].
Zeng YR; Chen MH; Yan K; Liao SR; Dai Y; Yang W; Li JY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3294-8. PubMed ID: 17313816
[TBL] [Abstract][Full Text] [Related]
17. [Application of contrast-enhanced ultrasound to increase the diagnostic rate of liver tumor by biopsy].
Wu W; Chen MH; Yan K; Yin SS; Dai Y; Fan ZH; Yang W; Li JY
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):116-20. PubMed ID: 16620718
[TBL] [Abstract][Full Text] [Related]
18. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma.
Pompili M; Riccardi L; Covino M; Barbaro B; Di Stasi C; Orefice R; Gasbarrini G; Rapaccini GL
Liver Int; 2005 Oct; 25(5):954-61. PubMed ID: 16162152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
